<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01109277</url>
  </required_header>
  <id_info>
    <org_study_id>2010ICTPAGR</org_study_id>
    <nct_id>NCT01109277</nct_id>
  </id_info>
  <brief_title>Prediction of Neonatal Hyperbilirubinemia</brief_title>
  <acronym>2010ICTPAGR</acronym>
  <official_title>An Evidence-based Strategy for Assessing the Risk of Significant Neonatal Hyperbilirubinemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Patras</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To develop an evidence-based strategy for assessing the risk of significant&#xD;
      hyperbilirubinemia in healthy term and near-term (late-preterm) neonates.&#xD;
&#xD;
      Hypothesis: A stepwise strategy which combines clinical parameters and serial non-invasive&#xD;
      transcutaneous bilirubin (TcB) values could reliably predict significant neonatal&#xD;
      hyperbilirubinemia.&#xD;
&#xD;
      Methods: Data from neonates &gt;34 weeks' gestation included in the registry for neonatal&#xD;
      hyperbilirubinemia of the well-baby nursery of the University Hospital of Patras, from&#xD;
      January 2008 to December 2010 will be reviewed.&#xD;
&#xD;
      The registry includes prospectively collected data such as sex, gestational age, gestation&#xD;
      and perinatal information, mother's and infant's ABO group and Rh, G6PD deficiency, Coombs&#xD;
      test, type of delivery and complications, birthweight, postnatal medications and&#xD;
      interventions, type and volume of feeding (daily), extension of jaundice, TcB measurements at&#xD;
      intervals of 12+/-4 hours until discharge, total serum bilirubin values (if obtained), TcB or&#xD;
      TSB measurements at follow-up, weight at discharge, need of phototherapy (inpatient or after&#xD;
      discharge). TcB and TSB values are plotted on a hour-specific chart.&#xD;
&#xD;
      A novel predictive nomogram based on TcB measurements (Varvarigou et al. Pediatrics&#xD;
      2009;124:1052-9) will be used to classify TcB values as high, intermediate, and low risk.&#xD;
&#xD;
      Significant hyperbilirubinemia will be defined as a TSB value above the phototherapy&#xD;
      threshold level according to the AAP 2004 guidelines&#xD;
&#xD;
      Statistics: Independent and joint effects of various clinical factors on the development of&#xD;
      significant hyperbilirubinemia will be evaluated by logistic regression analysis Cluster&#xD;
      analysis and Chi-squared Automatic Interaction Detection (CHAID) tree method will be used to&#xD;
      develop the strategy. At each step, CHAID chooses the independent (predictor) variable that&#xD;
      has the strongest interaction with the dependent variable. Categories of each predictor are&#xD;
      merged if they are not significantly different with respect to the dependent variable.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Risk of significant hyperbilirubinemia assessed by an evidence-based strategy</measure>
    <time_frame>Birth to 14th postnatal day</time_frame>
    <description>Risk for significant hyperbilirubinemia (defined as serum bilirubin values above the phototherapy threshold according to the American Academy of Pediatrics 2004 guidelines) assessed by a strategy which will combine clinical risk factors and non-invasive TcB measurements</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Hyperbilirubinemia, Neonatal</condition>
  <arm_group>
    <arm_group_label>Healthy term and late-preterm neonates</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy term and late-preterm neonates&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy term and late-preterm neonates&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Admission to the NICU&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anastasia Varvarigou, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Neonatal Intensive Care Unit, Department of Pediatrics, University Hospital of Patras</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sotirios Fouzas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatal Intensive Care Unit, University Hospital of Patras</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aggeliki Karatza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatal Intensive Care Unit, University Hospital of Patras</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lito Mantagou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric Department, University Hospital of Patras</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Well-baby nursery, Department of Pediatrics, University Hospital of Patras</name>
      <address>
        <city>Patras</city>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <study_first_submitted>April 21, 2010</study_first_submitted>
  <study_first_submitted_qc>April 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2010</study_first_posted>
  <last_update_submitted>January 18, 2011</last_update_submitted>
  <last_update_submitted_qc>January 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2011</last_update_posted>
  <responsible_party>
    <name_title>Fouzas Sotirios</name_title>
    <organization>Neonatal Intensive Care Unit, Department of Pediatrics, University Hospital of Patras</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperbilirubinemia, Neonatal</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

